Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Sales | 126,078 | 132,584 | 99,951 | 105,136 | 94,864 |
| Cost of Goods | 33,026 | 24,965 | 20,342 | 17,177 | 15,317 |
| Gross Profit | 93,052 | 107,619 | 79,609 | 87,959 | 79,547 |
| Operating Expenses | 98,723 | 103,434 | 102,048 | 81,433 | 81,115 |
| Operating Income | -5,645 | 5,150 | -22,097 | 6,703 | -1,251 |
| Interest Expense | 3,540 | 3,489 | 598 | 310 | 133 |
| Other Income | 1,679 | 826 | 202 | -47 | -70 |
| Pre-tax Income | -7,506 | 2,487 | -22,493 | 6,346 | -1,454 |
| Income Tax | 4,036 | 4,023 | 4,781 | 2,109 | -2,577 |
| Net Income Continuous | -11,542 | -1,536 | -27,274 | 4,237 | 1,123 |
| Net Income | $-11,542 | $-1,536 | $-27,274 | $4,237 | $1,123 |
| EPS Basic Total Ops | -0.82 | -0.11 | -1.96 | 0.31 | 0.08 |
| EPS Basic Continuous Ops | -0.82 | -0.11 | -1.96 | 0.31 | 0.08 |
| EPS Diluted Total Ops | -0.82 | -0.11 | -1.96 | 0.30 | 0.08 |
| EPS Diluted Continuous Ops | -0.82 | -0.11 | -1.96 | 0.30 | 0.08 |
| EPS Diluted Before Non-Recurring Items | -0.32 | 0.16 | -0.95 | 0.37 | 0.13 |
| EBITDA(a) | $3,352 | $14,037 | $-12,909 | $14,766 | $6,012 |